z-logo
open-access-imgOpen Access
Management of cystic echinococcosis in the last two decades: what have we learned?
Author(s) -
Virgínia Velasco-Tirado,
Ángela RomeroAlegría,
Javier PardoLledías,
Montserrat AlonsoSardón,
Amparo LópezBernús,
José E. Quiñones Sampedro,
Luis MuñozBellvís,
Alicia Iglesias Gómez,
Antonio Muro,
Juan Luis Muñoz Bellido,
Manuel Iglesias-Iglesias,
Marcelo F. Jiménez,
Moncef BelhassenGarcía
Publication year - 2018
Publication title -
transactions of the royal society of tropical medicine and hygiene
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 105
eISSN - 1878-3503
pISSN - 0035-9203
DOI - 10.1093/trstmh/try050
Subject(s) - medicine , albendazole , praziquantel , surgery , cystic echinococcosis , mortality rate , retrospective cohort study , echinococcosis , cyst , disease , schistosomiasis , helminths , immunology
Management options for cystic echinococcosis (CE) remain a serious problem. The main aim of this study was to examine the selection and complications of treatment applied in patients with CE. The second aim was to evaluate the mortality rate and causative factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom